azoxymethane has been researched along with pioglitazone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujisawa, N; Ishimine, S; Kadowaki, T; Kawamori, T; Matsuhashi, N; Nakagama, H; Nakajima, A; Ochiai, M; Osawa, E; Sekihara, H; Wada, K | 1 |
| Blumberg, RS; Fujisawa, N; Fujisawa, T; Ikeda, I; Kadowaki, T; Kubota, N; Kudo, C; Nakagama, H; Nakajima, A; Nakajima, N; Takahashi, H; Terauchi, Y; Tomimoto, A; Wada, K; Yonemitsu, K | 1 |
| Camargo, JA; Carvalheira, JBC; Carvalho, HF; Damas-Souza, DM; de Carvalho, RB; Dias, MM; Flores, MBS; Osório-Costa, F; Rocha, GZ; Ropelle, ER; Saad, MJA | 1 |
| Fujii, G; Komiya, M; Mutoh, M; Nakano, K; Takahashi, M; Takasu, S; Teraoka, N; Ueno, T; Wakabayashi, K; Yamamoto, M; Yanaka, A | 1 |
4 other study(ies) available for azoxymethane and pioglitazone
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.
Topics: Animals; Antineoplastic Agents; Azoxymethane; Carcinogens; Chromans; Colon; Colonic Neoplasms; Female; Immunohistochemistry; Ligands; Mice; Mice, Inbred BALB C; Pioglitazone; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2003 |
Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
Topics: Active Transport, Cell Nucleus; Animals; Azoxymethane; beta Catenin; Caco-2 Cells; Cell Proliferation; Cell Transformation, Neoplastic; Colon; Colonic Neoplasms; Epithelial Cells; Female; HT29 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Knockout; Pioglitazone; PPAR gamma; Protein Binding; RNA Interference; Signal Transduction; TCF Transcription Factors; Thiazolidinediones; Time Factors; Transfection | 2008 |
RETRACTED: Obesity-induced increase in tumor necrosis factor-α leads to development of colon cancer in mice.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Azoxymethane; Blotting, Western; Cell Proliferation; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Disease Models, Animal; Enzyme Activation; HT29 Cells; Humans; Hyperinsulinism; Hypoglycemic Agents; I-kappa B Kinase; Immunohistochemistry; Inflammation Mediators; Infliximab; Insulin; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Obesity; Phosphatidylinositol 3-Kinase; Pioglitazone; Proto-Oncogene Proteins c-akt; Signal Transduction; Thiazolidinediones; Time Factors; TOR Serine-Threonine Kinases; Tumor Burden; Tumor Necrosis Factor-alpha; Up-Regulation; Xenograft Model Antitumor Assays | 2012 |
Suppressive effect of pioglitazone, a PPAR gamma ligand, on azoxymethane-induced colon aberrant crypt foci in KK-Ay mice.
Topics: Aberrant Crypt Foci; Adipokines; Animals; Azoxymethane; Biomarkers; Carcinogens; Colorectal Neoplasms; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Hypoglycemic Agents; Immunoenzyme Techniques; Insulin; Intra-Abdominal Fat; Leptin; Lipids; Mice; Mice, Inbred C57BL; Obesity; Pioglitazone; PPAR gamma; Thiazolidinediones | 2012 |